FDA expands clearance for NinePoint's imaging device

04/29/2013 | MedGadget.com

The FDA has cleared NinePoint Medical to market its NvisionVLE Imaging System for esophageal tissue microstructure imaging. The device, which features technology designed to provide a 3D image of the scanned organ in less than a minute, was first cleared in 2012 to aid in human tissue microstructure evaluation by delivering 2D cross-sectional, real-time depth imaging.

View Full Article in:


Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Director, Site Quality Management
Minneapolis, MN
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC